Accelerator for Biosciences in Connecticut – ABCT – is a competitive entry, 6-month long program designed to provide entrepreneurship education and regional networking to seed-stage ventures...

Featuring: Graham Goodrich - SVP, Brand Marketing, Biohaven Pharmaceuticals John Grosso, Ph.D, Vice President, Chemistry, Manufacturing, & Controls, Arvinas Dawn Hocevar - President & CEO,...

Accelerator for Biosciences in Connecticut – ABCT – is a competitive entry, 6-month long program designed to provide entrepreneurship education and regional networking to seed-stage ventures...

"We can't teach what we don't know and we can't lead where we can't go" - Malcolm X With the backdrop of current events, please...

With $19 trillion, or nearly 85% of the value of the S&P 500 represented by intangible assets, investment in IP has changed the global landscape. ...

With $19 trillion, or nearly 85% of the value of the S&P 500 represented by intangible assets, investment in IP has changed the global landscape. ...

FEATURING: Leading Investigators, Top Biotech Proposals, Accelerated Awards up to $300K, and a Transformative Virtual Experience. See Yale's leading life sciences investigators with this year's top...

FEATURING: Leading Investigators, Top Biotech Proposals, Accelerated Awards up to $300K, and a Transformative Virtual Experience. See Yale’s leading life sciences investigators with this year’s top...

The second in a two-part series highlighting Connecticut's bioscience footprint. Co-organized by BioCT, PhRMA and the Bipartisan Bioscience Caucus, please join us for the second...

In seeking to combat emerging infectious diseases and other 21st century health threats, the path to better prepared, protected, and healthy individuals, families, and communities...